Environment, the Immune System, and Depression: An Integrative Review and Discussion of the Infection-Defense Hypothesis

Molecular and Integrative Toxicology

Volumn , Issue , 2012, Pages 345-385

  Tanaka, Midori ^a,b   Anders, Sherry ^a,c   Kinney, Dennis K ^a,c  

^a MCLEAN HOSPITAL   (United States)

^b Obara Hospital   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Depressive Symptom; Human Immunodeficiency Virus; Major Depressive Disorder; Proinflammatory Cytokine; West Nile Virus

Indexed keywords

EID: 84880359723     PISSN: 21684219     EISSN: 21684235     Source Type: Book Series    
DOI: 10.1007/978-1-61779-812-2_14     Document Type: Chapter

References (262)

1. Afsar B, Elsurer R, Eyileten T, Yilmaz MI, Caglar K (2009) Antibody response following hepatitis B vaccination in dialysis patients: does depression and quality of life matter? Vaccine 27:5865–5869
2. Alavanja MC, Hoppin JA, Kamel F (2004) Health effects of chronic pesticide exposure: cancer and neurotoxicity. Annu Rev Public Health 25:155–197
3. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders text revision, 4th edn. American Psychiatric Association, Washington
4. Anyanwu E, Campbell AW, Jones J, Ehiri JE, Akpan AI (2003) The neurological significance of abnormal natural killer cell activity in chronic toxigenic mold exposures. Scientific World Journal 3:1128–1137
5. Ardayfio P, Kim K (2006) Anxiogenic-like effect of chronic corticosterone in the light-dark emergence task in mice. Behav Neurosci 120:249–256
6. Arling TA, Yolken RH, Lapidus M, Langenberg P, Dickerson FB, Zimmerman SA, Balis T, Cabassa JA, Scrandis DA, Tonelli LH, Postolache TT (2009) Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis 197:905–908
7. Barefoot JC, Schroll M (1996) Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 93:1976–1980
8. Bartfai T, Schultzberg M (1993) Cytokines in neuronal cell types. Neurochem Int 22:435–444
9. Bartholomew JB, Morrison D, Ciccolo JT (2005) Effects of acute exercise on mood and well-being in patients with major depressive disorder. Med Sci Sports Exerc 37:2032–2037
10. Beck CT (1995) The effects of postpartum depression on maternal-infant interaction: a meta-analysis. Nurs Res 44:298–304
11. Beilin B, Rusabrov Y, Shapira Y, Roytblat L, Greemberg L, Yardeni IZ, Bessler H (2007) Low-dose ketamine affects immune responses in humans during the postoperative period. Br J Anaesth 99:522–527
12. Beloborodova EI, Lambrova EG, Beloborodova EV, Ostanko VL, Alekseeva AS, Kalacheva TP, Livshits IK (2010) Somatopsychic manifestations in patients with chronic viral hepatitis. Kin Med (Mosk) 88:42–45
13. Benkelfat C, Ellenbogen MA, Dean P, Palmour RM, Young SN (1994) Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 51:687–697
14. Bentley MW, Stas JM, Johnson JM, Viet BC, Garrett N (2005) Effects of preincisional ketamine treatment on natural killer cell activity and postoperative pain management after oral maxillo-facial surgery. AANA J 73:427–436
15. Benton TD, Crits-Cristoph P, Dubé B, Evans DI (2009) Animal models of mood disorders. In: Charney DS, Nestler EJ (eds) Neurobiology of mental illness, 3rd edn. Oxford University Press, New York
16. Berdoy M, Webster JP, Macdonald DW (2000) Fatal attraction in rats infected with Toxoplasma gondii. Proc Biol Sci 267:1591–1594
17. Berg PJ, Smallfield S, Svien L (2010) An investigation of depression and fatigue post West Nile virus infection. S D Med 63(127–129):131–133
18. Berk LS, Felten DL, Tan SA, Bittman BB, Westengard J (2001) Modulation of neuroimmune parameters during the eustress of humorassociated mirthful laughter. Altern Ther Health Med 7(62–72):74–76
19. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351–354
20. Berridge CW, Dunn AJ (1987) A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice. Horm Behav 21:393–401
21. Beseler CL, Stallones L (2008) A cohort study of pesticide poisoning and depression in Colorado farm residents. Ann Epidemiol 18:768–774
22. Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D, Ferstl R, von Eynatten M, Wendt T, Rudofsky G, Joswig M, Morcos M, Schwaninger M, McEwen B, Kirschbaum C, Nawroth PP (2003) A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA 100:1920–1925
23. Bloch M, Daly RC, Rubinow DR (2003) Endocrine factors in the etiology of postpartum depression. Compr Psychiatry 44:234–246
24. Bode L, Ludwig H (2003) Borna disease virus infection, a human mental-health risk. Clin Microbiol Rev 16:534–545
25. Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M (2002) Increased depressive ratings in patients with hepatitis C receiving interferon-α-based immunotherapy are related to interferon-α-induced changes in the serotonergic system. J Clin Psychopharmacol 22:86–90
26. Borges MC, Martini LA, Rogero MM (2011) Current perspectives on vitamin D, immune system, and chronic diseases. Nutrition 27:399–404
27. Boufidou F, Lambrinoudaki I, Argeitis J, Zervas IM, Pliatsika P, Leonardou AA, Petropoulos G, Hasiakos D, Papadias K, Nikolaou C (2009) CSF and plasma cytokines at delivery and postpartum mood disturbances. J Affect Disord 115:287–292
28. Brenner IK, Castellani JW, Gabaree C, Young AJ, Zamecnik J, Shephard RJ, Shek PN (1999) Immune changes in humans during cold exposure: effects of prior heating and exercise. J Appl Physiol 87:699–710
29. Brietzke E, Kapczinski F (2008) TNF-alpha as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 32:1355–1361
30. Broadhead W, Blazer D, George L, Tse CK (1990) Depression, disability days and days lost from work in a prospective epidemiological study. JAMA 264:2524–2528
31. Brown GW, Bifulco A, Harris T, Bridge L (1986) Life stress, chronic subclinical symptoms and vulnerability to clinical depression. J Affect Disord 11:1–19
32. Campbell LC, Clauw DJ, Keefe FJ (2003) Persistent pain and depression: a biopsychosocial perspective. Biol Psychiatry 54:399–409
33. Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, Miller AH (2002) Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26:643–652
34. Capuron L, Miller AH (2004) Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 56:819–824
35. Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, Miller AH (2003) Interferon-α-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment. Biol Psychiatry 54:906–914
36. Carek PJ, Laibstain SE, Carek SM (2011) Exercise for the treatment of depression and anxiety. Int J Psychiatry Med 41:15–28
37. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M (2003) Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 108:2317–2322
38. Ciesla JA, Roberts JE (2001) Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 158:725–730
39. Cohen M, Hoffman RG, Cromwell C, Schmeidler J, Ebrahim F, Carrera G, Endorf F, Alfonso CA, Jacobson JM (2002) The prevalence of distress in persons with human immunodeficiency virus infection. Psychosomatics 43:10–15
40. Cohen S (1995) Psychological stress and susceptibility to upper respiratory infections. Am J Respir Crit Care Med 152:S53–S58
41. Cohen S, Alper CM, Doyle WJ, Treanor JJ, Turner RB (2006) Positive emotional style predicts resistance to illness after experimental exposure to rhinovirus or influenza a virus. Psychosom Med 68:809–815
42. Cohen S, Kemeny ME, Kearney KA, Zegans LS, Neuhaus JM, Conant MA (1999) Persistent stress as predictor of genital herpes recurrence. Arch Intern Med 159:2430–2436
43. Compton WM, Conway KP, Stinson FS, Grant BF (2006) Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002. Am J Psychiatry 163:2141–2147
44. Cook JA, Grey D, Burke J, Cohen MH, Gurtman AC, Richardson JL, Wilson TE, Young MA (2004) Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health 94:1133–1140
45. Corsini E, Liesivuori J, Vergieva T, Van Loveren H, Colosio C (2008) Effects of pesticide exposure on the human immune system. Hum Exp Toxicol 27:671–680
46. Corwin EJ, Pajer K (2008) The psychoneuroimmunology of postpartum depression. J Womens Health (Larchmt) 17:1529–1534
47. Cummings EM, Davies PT (1994) Maternal depression and child development. J Child Psychol Psychiatry 35:73–112
48. Daley A (2008) Exercise and depression: a review of reviews. J Clin Psychol Med Settings 15:140–147
49. Dallaire F, Dewailly E, Muckle G, Vezina C, Jacobson SW, Jacobson JL, Ayotte P (2004) Acute infections and environmental exposure to organochlorines in Inuit infants from Nunavik. Environ Health Perspect 112:1359–1365
50. Dantzer R (2001) Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 15:7–24
51. Dantzer R (2009) Cytokines, sickness behavior, and depression. Immunol Allergy Clin North Am 29:247–264
52. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Neuroscience 9:46–57
53. Davis EP, Glynn LM, Schetter CD, Hobel C, Chicz-Demet A, Sandman CA (2007) Prenatal exposure to maternal depression and cortisol influences infant temperament. J Am Acad Child Adolesc Psychiatry 46:737–746
54. Dawlati Y, Herman N, Swardfager W, Sham L, Reim EK, Lanotôt KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446–457
55. der Does V (2001) The effects of tryptophan depletion on mood and psychiatric symptoms. J Affect Disord 64:107–119
56. Doyle C, Ewald S, Ewald P (2007) Premenstrual syndrome: an evolutionary perspective on its causes and treatment. Perspect Biol Med 50:181–202
57. Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4:11–22
58. Dunn AJ, Wang J (1995) Cytokine effects on CNS biogenic amines. Neuroimmunomodulation 2:319
59. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO (2005) Exercise treatment for depression: efficacy and dose response. Am J Prev Med 28:1–8
60. Eaton WW, Anthony JC, Gallo J (1997) Natural history of diagnostic interview schedule/DSM-IV and major depression. The Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry 54:993–999
61. Eaton WW, Shao H, Nestadt G (2008) Population-based study of first onset and chronicity in major depressive disorder. Arch Gen Psychiatry 65:513–520
62. Echols MR, O’Connor CM (2010) Depression after myocardial infarction. Curr Heart Fail Rep 7:185–193
63. Eley TC, Sugden K, Corsico A, Gregory AM, Sham P, McGuffin P, Plomin R, Craig IW (2004) Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 9:908–915
64. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, Nemeroff CB, Bremner JD, Carney RM, Coyne JC, Delong MR, Frasure-Smith N, Glassman AH, Gold PW, Grant I, Gwyther L, Ironson G, Johnson RL, Kanner AM, Katon WJ, Kaufmann PG, Keefe FJ, Ketter T, Laughren TP, Leserman J, Lyketsos CG, McDonald WM, McEwen BS, Miller AH, Musselman DL, O’Connor C, Petitto JM, Pollock BG, Robinson RG, Roose SP, Rowland J, Sheline Y, Sheps DS, Simon G, Spiegel D, Stunkard A, Sunderland T, Tibbits PJ, Valvo WJ (2005) Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 58:175–189
65. Evans DL, Lynch KG, Benton T, Dubé B, Gettes DR, Tustin NB, Lai JP, Metzger D, Douglas SD (2008) Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome. Biol Psychiatry 63:899–905
66. Evans DL, Ten Have TR, Douglas SD, Gettes DR, Morrison M, Chiappini MS, Brinker-Spence P, Job C, Mercer DE, Wang YL, Cruess D, Dube B, Dalen EA, Brown T, Bauer R, Petitto JM (2002) Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry 159:1752–1759
67. Fang CY, Reibel DK, Longacre ML, Rosenzweig S, Campbell DE, Douglas SD (2010) Enhanced psychosocial well-being following participation in a mindfulness-based stress reduction program is associated with increased natural cell activity. J Altern Complement Med 16:531–538
68. Fawzy FI, Kemeny ME, Fawzy NW et al (1990) A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry 47:729–735
69. Fazekas C, Enzinger C, Wallner M, Kischka U, Greimel E, Kapeller P, Stix P, Pieringer W, Fazekas F (2006) Depressive symptoms following herpes simplex encephalitis—an underestimated phenomenon? Gen Hosp Psychiatry 28:403–407
70. Fischler B, Bocken R, Schneider I, De Waele M, Thielemans K, Derde MP (1992) Immune changes induced by electroconvulsive therapy (ECT). Ann N Y Acad Sci 650:326–330
71. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS (1997) Chronic pain associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 13:116–137
72. Flegr J, Havlicek J, Kodym P, Maly M, Smahel Z (2002) Increased risk of traf fi c accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect Dis 2:11
73. Frank MG, Hendricks SE, Johnson DR, Wieseler JL, Burke WJ (1999) Antidepressants augment natural killer cell activity: in vivo and in vitro. Neuropsychobiology 39:18–24
74. Frank MG, Hendricks SE, Burke WJ, Johnson DR (2004) Clinical response augments NK cell activity independent of treatment modality: a randomized double-blind placebo controlled antidepressant trial. Psychol Med 34:491–498
75. Frasure-Smith N, Lespérance F (2003) Depression—a cardiac risk factor in search of treatment. JAMA 289:3171–3173
76. Freeman MP, Rapaport MH (2011) Omega-3 fatty acids and depression: from cellular mechanisms to clinical care. J Clin Psychiatry 72:258–259
77. Galloway T, Handy R (2003) Immunotoxicity of organophosphorous pesticides. Ecotoxicology 12:345–363
78. Ganji V, Milone C, Cody MM, McCarty F, Wang YT (2010) Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. Int Arch Med 11:3–29
79. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T (2005) Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 106:1071–1083
80. Glaser R, Robles TF, Sheridan J, Malarkey WB, Kiecolt-Glaser JK (2003) Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry 60:1009–1014
81. Goldberg D (2006) The aetiology of depression. Psychol Med 36:1341–1347
82. Goldenberg DL (2010) The interface of pain and mood disorders in the rheumatic diseases. Semin Arthritis Rheum 40:15–31
83. Golding J, Steer C, Emmett P, Davis JM, Hibbeln JR (2009) High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology 20:598–603
84. Goundasheva D, Andonova M, Ivanov V (1994) Changes in some parameters of the immune response in rats after cold stress. Zentralbl Veterinarmed B 41:670–674
85. Graeff FG (1997) Serotonergic systems. Psychiatr Clin North Am 20:723–739
86. Greden JF (2001) The burden of disease for treatment-resistant depression. J Clin Psychiatry 62(suppl 16):26–31
87. Groër MW, Davis MW (2006) Cytokines, infections, stress, and dysphoric moods in breastfeeders and formula feeders. J Obstet Gynecol Neonatal Nurs 35:599–607
88. Groër MW, Davis MW, Smith K, Casey K, Kramer V, Bukovsky E (2005) Immunity, inflammation and infection in post-partum breast and formula feeders. Am J Reprod Immunol 54:222–231
89. Groër MW, Morgan K (2007) Immune, health and endocrine characteristics of depressed postpartum mothers. Psychoneuroendocrinology 32:133–139
90. Haaland DA, Sabljic TF, Baribeau DA, Mukovozov IM, Hart LE (2008) Is regular exercise a friend or foe of the aging immune system? A systemic review. Clin J Sport Med 18:539–548
91. Hammen C (2005) Stress and depression. Annu Rev Clin Psychol 1:293–319
92. Hart BL (1988) Biological basis of the behavior of sick animals. Neurosci Biobehav Immun 12:123–137
93. Hay DF, Pawlby S, Angold A, Harold GT, Sharp D (2003) Pathways to violence in the children of mother who were depressed postpartum. Dev Psychol 39:1083–1094
94. Heinrich A, Adamaszek M (2010) Anti-Borna disease virus antibody responses in psychiatric patients: long-term follow up. Psychiatry Clin Neurosci 64:255–261
95. Herbert TB, Cohen S (1993) Depression and immunity: a meta-analytic review. Psychol Bull 113:472–486
96. Hestad KA, Tønseth S, Stoen CD, Ueland T, Aukrust P (2003) Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT 19:183–188
97. Hestad KA, Aukrust P, Tønseth S, Klæbo Reitan S (2009) Depression has a strong relationship to alterations in the immune, endocrine and neural system. Curr Psychiatry Rev 5:287–297
98. Hibbeln JR (2009) Depression, suicide and deficiencies of omega-3 essential fatty acids in modern diets. World Rev Nutr Diet 99:17–30
99. Hirschfeld RM (2000) History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 61(suppl 6):4–6
100. Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477–501
101. Horesh N, Klomek AB, Apter A (2008) Stressful life events and major depressive disorders. Psychiatry Res 160:192–199
102. Huan M, Hamazaki K, Sun Y, Itomura M, Liu H, Kang W, Watanabe S, Terasawa K, Hamazaki T (2004) Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China. Biol Psychiatry 56:490–496
103. Hudson JI, Mangweth B, Pope HG Jr, De Col C, Hausmann A, Gutweniger S, Laird NM, Biebl W, Tsuang MT (2003) Family study of affective spectrum disorder. Arch Gen Psychiatry 60:170–177
104. Husain MM, Rush AJ, Fink M, Knapp R, Petrides G, Rummans T, Biggs MM, O’Connor K, Rasmussen K, Litle M, Zhao W, Bernstein HJ, Smith G, Mueller M, McClintock SM, Bailine SH, Kellner CH (2004) Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. J Clin Psychiatry 65:485–491
105. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman O, Boland RJ, Moore J; HIV Epidemiology Research Study Group (2001) Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 285:1466–1474
106. Irwin M (2002a) Effects of sleep and sleep loss on immunity and cytokines. Brain Behav Immun 16:503–512
107. Irwin M (2002b) Psychoneuroimmunology of depression: clinical implications. Brain Behav Immun 16:1–16
108. Irwin MR, Carrillo C, Olmstead R (2010) Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav Immun 24:54–57
109. Irwin M, Lacher U, Caldwell C (1992) Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects. Psychol Med 22:1045–1050
110. Irwin MR, Miller AH (2007) Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 21:374–383
111. Johnson C, Eccles R (2005) Acute cooling of the feet and the onset of common cold symptoms. Fam Pract 22:608–613
112. Jones-Brando L, Torrey EF, Yolken R (2003) Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 62:237–244
113. Kallioniemi MK, Simola AJ, Kymalainen HR, Vesala HT, Louhelainen JK (2009) Mental symptoms among Finnish farm entrepreneurs. Ann Agric Environ Med 16:159–168
114. Katafuchi T, Kondo T, Take S, Yoshimura M (2006) Brain cytokines and the 5-HT system during poly 1:C-induced fatigue. Ann N Y Acad Sci 1088:230–237
115. Katon W, Russo J (1989) Somatic symptoms and depression. J Fam Pract 29:65–69
116. Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, Mueller M, Bernstein HJ, O’Connor K, Smith G, Biggs M, Bailine SH, Malur C, Yim E, McClintock S, Sampson S, Fink M (2006) Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 63:1337–1344
117. Kendler KS, Karkowski LM, Prescott CA (1999) Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 156:837–841
118. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B (2005) The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 62:529–535
119. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence of age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry 62:593–602
120. Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Glaser R (2011) Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav Immun 25(8):1725–1734
121. Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R (2002) Psychoneuroimmunology: psychological influences on immune function and health. J Consult Clin Psychol 70:537–547
122. Kinney DK, Tanaka M (2009) An evolutionary hypothesis of depression and its symptoms, adaptive value, and risk factors. J Nerv Ment Dis 197:561–567
123. Kling MA, Alesci S, Csako G, Costello R, Luckenbaugh DA, Bonne O, Duncko R, Drevets WC, Manji HK, Charney DS, Gold PW, Neumeister A (2007) Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A. Biol Psychiatry 62:309–313
124. Kluger MJ (1991) Fever: role of pyrogens and cryogens. Physiol Rev 71:93–127
125. Knijff EM, Breunis MN, Kupka RW, de Wit HJ, Ruwhof C, Akkerhuis GW, Nolen WA, Drexhage HA (2007) An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disord 9:743–753
126. Kook AI, Mizruchin A, Odnopozov N, Gershon H, Segev Y (1995) Depression and immunity: the biochemical interrelationship between the central nervous system and the immune system. Biol Psychiatry 37:817–819
127. Kopinsky KL, Stoff DM, Rausch DM (2004) Workshop report: the effects of psychological variables on the progression of HIV-1 disease. Brain Behav Immun 18:246–261
128. Kristiansen JE, Thomsen VF, Martins A, Viveiros M, Amaral L (2010) Non-antibiotic reverse resistance of bacteria to antibiotics. In Vivo 24:751–754
129. Kronfol Z, Nair MP, Weinberg V, Young EA, Aziz M (2002) Acute effects of electroconvulsive therapy on lymphocyte natural killer cell activity in patients with major depression. J Affect Disord 71:211–215
130. Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M (2001) Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol 21:199–206
131. Kwiatkowski DP (2005) How malaria has affected the genome and what human genetics can teach us about malaria. Am J Hum Genet 77:171–192
132. Lam RW, Song C, Yatham LN (2004) Does neuroimmune dysfunction mediate seasonal mood changes in winter depression? Med Hypotheses 63:567–573
133. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370–379
134. Leserman J (2008) Role of depression, stress, and trauma in HIV disease progression. Psychosom Med 70:539–545
135. Lestage J, Verrier D, Palin K, Dantzer R (2002) The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav Immun 16:596–601
136. Lewis MD, Hibbeln JR, Johnson JE, Lin YH, Hyun DY, Loewke JD (2011) Suicide deaths of active-duty US Military and omega-3 fatty-acid status: a case-control comparison. J Clin Psychiatry 72(12):1585–1590
137. Lieb J (2007) Lithium and antidepressants: stimulating immune function and preventing and reversing infection. Med Hypotheses 69:8–11
138. Lima CS, Ribeiro-Carvalho A, Filgueiras CC, Manhães AC, Meyer A, Abreu-Villaça Y (2009) Exposure to methamidophos at adulthood elicits depressive-like behavior in mice. Neurotoxicology 30:471–478
139. Lipkin WI, Hornig M (2004) Psychotropic viruses. Curr Opin Microbiol 7:420–425
140. Loftis JM, Huckans M, Morasco BJ (2010) Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis 37:519–533
141. London L, Flisher AJ, Wesseling C, Mergler D, Kromhout H (2005) Suicide and exposure to organophosphate insecticides: cause or effect? Am J Ind Med 47:308–321
142. Lustberg L, Reynolds CF (2000) Depression and insomnia: questions of cause and effect. Sleep Med Rev 4:253–262
143. Lyketsos CG, Hoover DR, Guccione M, Senterfitt W, Dew MA, Wesch J, VanRaden MJ, Treisman GJ, Morgenstern H (2009) Depressive symptoms as predictors of medical outcomes in HIV infection. Multicenter AIDS Cohort Study. JAMA 270:2563–2567
144. Maeng S, Zarate CA Jr (2007) The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 9:467–474
145. Maes M (1999) Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461:25–46
146. Maes M (2001) The immunoregulatory effects of antidepressants. Hum Psychopharmacol 16:95–103
147. Maes M, Lin AH, Ombelet W, Stevens K, Kenis G, De Jongh R, Cox J, Bosmans E (2000) Immune activation in the early puerperium is related to postpartum anxiety and depressive symptoms. Psychoneuroendocrinology 25:121–137
148. Maes M, Meltzer HY, Stevens W, Cosyns P, Blockx P (1994) Multiple reciprocal relationships between in vivo cellular immunity and hypothalamic-pituitary-adrenal axis in depression. Psychol Med 24:167–177
149. Maes M, Smith R, Scharpe S (1995) The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 20:111–116
150. Magnusson A (2000) An overview of epidemiological studies on seasonal affective disorder. Acta Psychiatry Scand 101:176–184
151. Maier SF, Watkins LR (1998) Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 105:83–107
152. Marsland AL, Cohen S, Rabin BS, Manuck SB (2006) Trait positive affect and antibody response to hepatitis B vaccination. Brain Behav Immun 20:261–269
153. Masuda A, Nakayama T, Yamanaka T, Koga Y, Tei C (2002) The prognosis after multidisciplinary treatment for patients with postinfectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome. J Behav Med 25:487–497
154. Matsunaga M, Isowa T, Kimura K, Miyakoshi M, Kanayama N, Murakami H, Sato S, Konagaya T, Nogimori T, Fukuyama S, Shinoda J, Yamada J, Ohira H (2008) Associations among central nervous, endocrine, and immune activities when positive emotions are elicited by looking at a favorite person. Brain Behav Immun 22:408–417
155. McNamara RK, Jandacek R, Rider T, Tso P, Cole-Strauss A, Lipton JW (2010) Omega-3 fatty acid deficiency increases constitutive proinflammatory cytokine production in rats: relationship with central serotonin turnover. Prostaglandins Leukot Essent Fatty Acids 83:185–191
156. Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, Manchester L, Reiter RJ (2010) Basic mechanisms involved in the anti-cancer effects of melatonin. Curr Med Chem 17:4462–4481
157. Mellor AL, Munn DH (2008) Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat Rev Immunol 8:74–80. Erratum in Nat Rev Immunol 8:160
158. Meyer A, Koifman S, Koifman RJ, Moreira JC, deRezende CJ, Abreu-Villaca Y (2010) Mood disorders hospitalizations, suicide attempts, and suicide mortality among agricultural workers and residents in an area with intensive use of pesticides in Brazil. J Toxicol Environ Health 73:866–877
159. Milaneschi Y, Shardell M, Corsi AM, Vazzana R, Bandinelli GJM, Ferrucci L (2010) Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab 95:3225–3233
160. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR (2008) Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26:971–982
161. Miller AH, Raison CL (2008) Immune system contributions to the pathophysiology of depression. Focus 6:36–45
162. Mizruchin A, Gold I, Krasnov I, Livshitz G, Shahin R, Kook AI (1999) Comparison of the effects of dopaminergic and serotonergic activity in the CNS on the activity of the immune system. J Neuroimmunol 101:201–204
163. Moreau M, Andre C, O’Connor JC, Dumich SA, Woods JA, Kelley KW, Dantzer R, Lestage J, Castanon N (2008) Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior. Brain Behav Immun 22:1087–1095
164. Moreira A, Delgado L, Moreira P, Haahtela T (2009) Does exercise increase the risk of upper respiratory tract infections? Br Med Bull 90:111–131
165. Morimoto K, Hooper DC, Bornhorst A, Corisdeo S, Bette M, Fu ZF, Schäfer MK, Koprowski H, Weihe E, Dietzschold B (1996) Intrinsic responses to Borna disease virus infection of the central nervous system. Proc Natl Acad Sci USA 93:13345–13350
166. Motivala SJ, Sarfatti A, Olmos L, Irwin MR (2005) Inflammatory markers and sleep disturbance in major depression. Psychosom Med 67:187–194
167. Mourtzoukou EG, Falagas ME (2007) Exposure to cold and respiratory tract infections. Int J Tuberc Lung Dis 11:938–943
168. Müller N (2010) COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence. Curr Opin Investig Drugs 11:31–42
169. Müller N, Schwarz MJ (2008) A psychoneuroimmunological perspective to Emil Kraepelin’s dichotomy: schizophrenia and major depression as inflammatory CNS disorders. Eur Arch Psychiatry Clin Neurosci 258(suppl 2):97–106
170. Mundt C, Reck C, Backenstrass M, Kronmuller K, Fiedler P (2000) Reconfirming the role of life events for the timing of depressive episodes. A two-year prospective follow-up study. J Affect Disord 59:23–30
171. Munoz-Bellido JL, Munoz-Criado S, Garcìa-Rodrìguez JA (2000) Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors. Int J Antimicrob Agents 14:177–180
172. Murray CJL, Lopez AD (1996) The global burden of disease. World Health Organization, Geneva
173. Murray KO, Resnick M, Miller V (2007) Depression after infection with West Nile virus. Emerg Infect Dis 13:479–481
174. Myint AM, Kim YK (2003) Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 61:519–525
175. Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R (2007) Anxiety, depression and cause-specific mortality: the HUNT study. Psychosom Med 69:323–331
176. Nemeroff CB, Widerlöv E, Bissette G, Walléus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226:1342–1344
177. Nery FG, Borba EF, Viana VS, Hatch JP, Soares JC, Bonfá E, Neto FL (2008) Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies. Prog Neuropsychopharmacol Biol Psychiatry 32:695–700
178. Ng CG, Boks MP, Zainal NZ, de Wit NJ (2011) The prevalence and pharmacotherapy of depression in cancer patients. J Affect Disord 131:1–7
179. Nieman DC (2000) Special feature for the Olympics: effects of exercise on the immune system: exercise effects on systemic immunity. Immunol Cell Biol 78:496–501
180. Nieman DC, Henson DA, Austin MD, Brown VA (2005) Immune response to a 30-minute walk. Med Sci Sports Exerc 37:57–62
181. Nieman DC, Nehlsen-Cannarella SL, Markoff PA, Balk-Lamberton AJ, Yang H, Chritton DB, Lee JW, Arabatzis K (1990) The effects of moderate exercise training on natural killer cells and acute upper respiratory tract infections. Int J Sports Med 11:467–473
182. Nimitphong H, Holick MF (2011) Vitamin D, neurocognitive functioning and immunocompetence. Curr Opin Clin Nutr Metab Care 14:7–14
183. Noaghiul S, Hibbeln JR (2003) Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry 160:2222–2227
184. Novati A, Roman V, Cetin T, Hagewoud R, den Boer JA, Luiten PG, Meerlo P (2008) Chronically restricted sleep leads to depression-like changes in neurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats. Sleep 31:1579–1585
185. Nunes SO, Itano EN, Amarante MK, Reiche EM, Miranda HC, de Oliveira CE, Matsuo T, Vargas HO, Watanabe MA (2008) RNA from Borna disease virus in patients with schizophrenia, schizoaffective patients, and in their biological relatives. J Clin Lab Anal 22:314–320
186. O’Brien SM, Fitzgerald P, Scully P, Landers A, Scott LV, Dinan TG (2007) Impact of gender and menstrual cycle phase on plasma cytokine concentrations. Neuroimmunomodulation 14:84–90
187. O’Connor JC, Lawson MA, André C, Briley EM, Szegedi SS, Lestage J, Castanon N, Herkenham M, Dantzer R, Kelley KW (2009a) Induction of IDO by Bacillus Calmette-Guérin is responsible for development of murine depressive-like behavior. J Immunol 182:3202–3212
188. O’Connor JC, Lawson MA, André C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R (2009b) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14:511–522
189. Orange JS, Ballas ZK (2006) Natural killer cells in human health and disease. Clin Immunol 118:1–10
190. Ostensen M, Forger F, Nelson J, Schuhmacher A, Hebisch G, Villiger P (2005) Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis 64:839–844
191. Owens MJ, Nemeroff CB (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425–473
192. Pace TW, Hu F, Miller AH (2007) Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 21:9–19
193. Pariante CM, Lightman SL (2008) The HPA-axis in major depression: classical theories and new developments. Trends Neurosci 31:464–468
194. Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D (2006) Omega-3 fatty acids and mood disorders. Am J Psychiatry 163:969–978. Erratum in Am J Psychiatry 163:1842
195. Pedersen CA, Stern RA, Pate J, Senger MA, Bowes WA, Mason GA (1993) Thyroid and adrenal measures during late pregnancy and the puerperium in women who have been major depressed or who become dysphoric postpartum. J Affect Disord 29:201–211
196. Poole S, Woolf CJ (1999) Cytokine-nerve growth factor interactions in inflammatory hyperalgesia. In: Watkins LR, Maier SF (eds) Cytokines and pain. Birkhauser, Basel
197. Pressman SD, Cohen S (2005) Does positive affect influence health? Psychol Bull 131:925–971
198. Rabinowitz J, Mark M, Popper M, Feldman D (1997) Physical illness among all discharged psychiatric inpatients in a national case register. J Ment Health Adm 24:82–89
199. Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24–31
200. Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K, Miller AH (2010) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15:393–403
201. Raison CL, Miller AH (2003) Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 54:283–294
202. Reed J, Ones DS (2006) The effect of acute aerobic exercise on positive activated affect: a meta-analysis. Psychol Sport Exerc 7:477–514
203. Reiche EM, Nunes SO, Morimoto HK (2004) Stress, depression, the immune system, and cancer. Lancet Oncol 5:617–625
204. Riccieri V, Spadaro A, Parisi G, Taccari E, Moretti T, Bernardini G, Favaroni M, Strom R (2000) Down-regulation of natural killer cells and of gamma/delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity? Lupus 9:333–337
205. Riedel WJ, Klaassen T, Schmitt JA (2002) Tryptophan, mood, and cognitive function. Brain Behav Immun 16:581–589
206. Rivier C, Vale W, Brown M (1989) In the rat, interleukin-1 α and-β stimulate adrenocorticotropin and catecholamine release. Endocrinology 125:3096–3102
207. Robinson FP, Mathews HL, Witek-Janusek L (2003) Psycho-endocrine immune response to mindfulness-based stress reduction in individuals infected with the human immunodeficiency virus: a quasiexperimental study. J Altern Complement Med 9:683–694
208. Rubinow DR, Schmidt PJ, Meltzer-Brody S, Harsh V (2009) The neurobiology of menstrual cycle-related mood disorders. In: Charney DS, Nestler EJ (eds) Neurobiology of mental illness, 3rd edn. Oxford University Press, New York
209. Saito S, Sakai M, Sakai Y, Tanebe K, Tsuda H, Michimata T (1999) Quantitative analysis of peripheral blood Th0, Th1, Th2, and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 117:550–555
210. Schatzberg AF (2000) Current status of managing depression: is there a need for new treatment strategies? In: Program and abstracts of the 153rd annual meeting of the American Psychiatric Association, Chicago
211. Schiepers OJG, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29:201–217
212. Schleifer SJ, Keller SE, Bond RN, Cohen J, Stein M (1989) Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization. Arch Gen Psychiatry 46:81–87
213. Schöning B, Elepfandt P, Lanksch WR, Volk HD, Woiciechowsky C (1999) Continuous infusion of proinflammatory cytokines into the brain to study brain cytokine induced local and systemic immune effects. Brain Res Brain Res Protoc 4:217–222
214. Schwemmle M (2001) Borna disease virus infection in psychiatric patients: are we on the right track? Lancet Infect Dis 1:46–52
215. Scott LV, Dinan TG (2002) Vasopressin as a target for antidepressant development: an assessment of the available evidence. J Affect Disord 72:113–124
216. Segerstrom SC (2010) Resources, stress, and immunity: an ecological perspective on human psychoneuroimmunology. Ann Behav Med 40:114–125
217. Seth V, Ahmad RS, Suke SG, Pasha ST, Bhattacharya A, Banerjee BD (2005) Lindane-induced immunological alterations in human poisoning cases. Clin Biochem 38:678–680
218. Seth V, Banerjee BD, Ahmed RS, Bhattacharya A, Pasha ST (2008) Alterations in immunoglobulins and cytokine levels in blood of malathion poisoning cases. Indian J Biochem Biophys 45:209–211
219. Shaman J, Pitzer VE, Viboud C, Grenfell BT, Lipsitch M (2010) Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biol 8:e1000316. doi:1371/journal.pbio.1000316
220. Shankar V, Kao M, Hamir AN, Sheng H, Koprowski H, Dietzschold B (1992) Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus. J Virol 66:992–998
221. Shephard RJ, Shek PN (1999) Effects of exercise and training on natural killer cell counts and cytolytic activity. Sports Med 28:177–195
222. Shuto H, Kataoka Y, Horikawa T, Fujihara N, Oishi R (1997) Repeated interferon-α administration inhibits dopaminergic neural activity in the mouse brain. Brain Res 747:348–351
223. Sillaber I, Holsboer F, Wotjak CT (2009) Animal models of mood disorders. In: Charney DS, Nestler EJ (eds) Neurobiology of mental illness, 3rd edn. Oxford University Press, New York
224. Singh NA, Stavrinos TM, Scarbek Y, Galambos G, Liber C, Fiatarone Singh MA (2005) A randomized controlled trial of high versus low intensity weight training versus general practitioner care for clinical depression in older adults. J Gerontol A Biol Sci Med Sci 60:768–776
225. Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35:298–306. Erratum in Med Hypotheses 36:178
226. Souza SS, Castro FA, Mendonca HC, Palma PV, Morais FR, Ferriani RA, Voltarelli JC (2001) Influence of menstrual cycle on NK activity. J Reprod Immunol 50:151–159
227. Spillman MK, Van der Does AJ, Rankin MA, Vuolo RD, Alpert JE, Nierenberg AA, Rosenbaum JF, Hayden D, Schoenfeld D, Fava M (2001) Tryptophan depletion in SSRI-recovered depressed outpatients. Psychopharmacology 155:123–127
228. Stein M, Miller AH, Trestman RL (1991) Depression, the immune system, and health and illness: findings in search of meaning. Arch Gen Psychiatry 48:171–177
229. Struyf NJ, Snoeck HW, Bridts CH, De Clerck LS, Stevens WJ (1990) Natural killer cell activity in Sjörgen’s syndrome and systemic lupus eythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes. Ann Rheum Dis 49:690–693
230. Suarez EC (2008) Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun 22:960–968
231. Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ (2006) Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 163:1100–1102
232. Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157:1552–1562
233. Tanaka M, Kinney DK (2011) Does the immune system regulate mood to defend against infection? Evidence from studies of immune factors, depression, and antidepressants. Curr Psychiatry Rev 7:57–66
234. Tanskanen A, Hibbeln JR, Hintikka J, Haatainen K, Honkalampi K, Viinamäki H (2001) Fish consumption, depression, and suicidality in a general population. Arch Gen Psychiatry 58:512–513
235. Tate AK, Petruzzello SJ (1995) Varying the intensity of acute exercise: implications for changes in affect. J Sports Med Phys Fitness 35:295–302
236. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E (2003) Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 170:429–433
237. Turnbull AV, Rivier C (1995) Regulation of the HPA-axis by cytokines. Brain Behav Immun 9:253–275
238. Udoji F, Martin T, Etherton R, Whalen MM (2010) Immunosuppressive effects of triclosan, nonylphenol, and DDT on human natural killer cells in vitro. J Immunotoxicol 7:205–212
239. van Wijngaarden E (2003) An exploratory investigation of suicide and occupational exposure. J Occup Environ Med 45:96–101
240. Veenstra van Nieuwenhoven AL, Bouman A, Moes H, Heineman MJ, de Leij LF, Santema J, Faas MM (2003) Endotoxin-induced cytokine production of monocytes of third-trimester pregnant women compared with women in the follicular phase of the menstrual cycle. Am J Obstet Gynecol 188:1073–1077
241. Vyas A, Kim SK, Sapolsky RM (2007) The effects of toxoplasma infection on rodent behavior are dependent on dose of the stimulus. Neuroscience 148:342–348
242. Waterloo K, Omdal R, Husby G, Mellgren SI (1998) Emotional status in systemic lupus erythematosus. Scand J Rheumatol 27:410–414
243. Watkins LR, Maier SF (2000) The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 51:29–57
244. Webster JP (2007) The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. Schizophr Bull 33:752–756
245. Weinstein AA, Kallman Price J, Stepanova M, Poms LW, Fang Y, Moon J, Nader F, Younossi ZM (2011) Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. Psychosomatics 52:127–132
246. Weiss RA, McMichael AJ (2004) Social and environmental risk factors in the emergence of infectious diseases. Nat Med 10:S70–S76
247. Weisse CS (1992) Depression and immunocompetence: a review of the literature. Psychol Bull 111:475–489
248. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK (1996) Cross-national epidemiology of major depression and bipolar disorder. JAMA 276:293–299
249. Wichers MC, Maes M (2004) The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-α-induced depression. J Psychiatry Neurosci 29:11–17
250. Witek-Janusek L, Albuquerque K, Chroniak KR, Chroniak C, Durazo-Aryizu R, Mathews HL (2008) Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun 22:969–981
251. Wolf JM, Rohleder N, Bierhaus A, Nawroth PP, Kirschbaum C (2009) Determinants of the NF-kappa B response to acute psychosocial stress in humans. Brain Behav Immun 23:742–749
252. Won SJ, Lin MT (1995) Thermal stresses reduce natural killer cell cytotoxicity. J Appl Physiol 79:732–737
253. Woods JA, Viera VJ, Keylock KT (2009) Exercise, inflammation, and innate immunity. Immunol Allergy Clin North Am 29:381–393
254. World Health Organization (2001) The world health report 2001: mental health: new understanding, new hope. World Health Organization, Geneva
255. Yates WR, Gleason O (1998) Hepatitis C and depression. Depress Anxiety 7:188–193
256. Yereli K, Balcioğlu IC, Ozbilgin A (2006) Is Toxoplasma gondii a potential risk for traffic accidents in Turkey? Forensic Sci Int 163:34–37
257. Yirmiya R, Pollak Y, Morag M, Reichenberg A, Barak O, Avitsur R, Shavit Y, Ovadia H, Weidenfeld J, Morag A, Newman ME, Pollmacher T (2000) Illness, cytokines and depression. Ann N Y Acad Sci 917:478–487
258. Zajecka J, Schatzberg A, Stahl S, Shah A, Caputo A, Post A (2010) Efficacy and safety of ago-melatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol 30:135–144
259. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856–864
260. Zhu CB, Blakely RD, Hewlett WA (2006) The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha active serotonin transporters. Neuropsychopharmacology 31:2121–2131
261. Zorilla EP, McKay JR, Luborsky L, Schmidt K (1996) Relation of stressors and depressive symptoms to clinical progression of viral illness. Am J Psychiatry 153:626–635
262. Zorilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K (2001) The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15:199–226